← Back to Clinical Trials
Recruiting NCT06296134

NCT06296134 Perineal Massage in Pregnancy to Reduce the Levator Ani Coactivation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06296134
Status Recruiting
Phase
Sponsor Azienda Sanitaria Universitaria Friuli Centrale
Condition Pelvic Floor Disorders
Study Type INTERVENTIONAL
Enrollment 58 participants
Start Date 2024-08-01
Primary Completion 2024-12-31

Trial Parameters

Condition Pelvic Floor Disorders
Sponsor Azienda Sanitaria Universitaria Friuli Centrale
Study Type INTERVENTIONAL
Phase N/A
Enrollment 58
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2024-08-01
Completion 2024-12-31
Interventions
perineal massage

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to test the efficacy of the perineal massage in reducing the levator ani muscle (LAM) co-activation. This phenomenon is characterized by the LAM contraction rather than its relaxation during the Valsalva maneuver and it is associated with adverse obstetric outcome. Participants who co-activate will be enrolled and randomized in 2 groups: group A, where women themselves perform the perineal massage during the third trimester of pregnancy and group B, where women undergo the standard care. Researchers will compare these groups to see if the perineal massage is able to reduce LAM co-activation.

Eligibility Criteria

Inclusion Criteria: pregnant women with the following characteristics: * nulliparous * single pregnancy * cephalic presentation of the fetus * Italian language fluency Exclusion Criteria: * multiparous * age \< 18 y, age \> 40 y * previous urinary or fecal incontinence * contraindications to vaginal delivery (such as placenta previa, vasa previa, etc) * twin pregnancy * language barrier * BMI at or \> 30

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology